The NCCN Guidelines for Survivorship outline recommendations for the management of anthracycline-induced cardiotoxicity, lymphedema, and infection prevention in adult-onset cancer survivors.
The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for anthracycline-induced cardiotoxicity and lymphedema in adult-onset cancer survivors.
The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for common physical and psychosocial consequences of cancer and cancer treatment to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period. This portion of the guidelines describes recommendations regarding the management of anthracycline-induced cardiotoxicity and lymphedema. In addition, recommendations regarding immunizations and the prevention of infections in cancer survivors are included.
Denlinger et al. (Mon,) conducted a review in Cancer survivorship. NCCN Guidelines for Survivorship was evaluated. The NCCN Guidelines for Survivorship outline recommendations for the management of anthracycline-induced cardiotoxicity, lymphedema, and infection prevention in adult-onset cancer survivors.